Clearing the smoke around the TB-HIV syndemic: smoking as a critical issue for TB and HIV treatment and care.
A Jackson-Morris, P I Fujiwara, E Pevzner
https://pubmed.ncbi.nlm.nih.gov/26260816/Actively Recruiting
Led by University of Southern California · Updated on 2023-11-28
800
Participants Needed
2
Research Sites
52 weeks
Total Duration
Researchers are evaluating the effectiveness of a phone-based tobacco cessation program specifically designed for people living with HIV PLWH in Uganda and Zambia. This study compares this intervention to the standard care, which includes brief advice to quit smoking and nicotine replacement therapy using nicotine patches. The research aims to understand how well this approach works, how feasible it is to deliver, and how affordable it might be in healthcare settings with varying tobacco use, policies, and resources. Participants are assigned to one of four groups standard care with advice to quit, standard care plus nicotine patches, standard care plus supportive text messaging, or a combination of all three. The study uses a previously tested SMS platform to provide tailored support messages. This design allows researchers to see which combination helps maintain tobacco abstinence over six months after starting the program. During the study, participants will be monitored for tobacco use abstinence at several points, including 4 weeks, 8 weeks, 3 months, and especially at 6 months after enrollment, which is the main outcome. The study also tracks feasibility and acceptability of the interventions within HIV treatment centers. Participants will undergo assessments to support these measurements, with ongoing engagement through text messaging and nicotine therapy where applicable, providing insight into the best ways to support quitting tobacco among PLWH in these regions.
CONDITIONS
Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Southern California
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants receive tobacco cessation interventions which may include nicotine replacement therapy, text message support, or both, along with standard advice to quit.
Visits at 4 weeks, 8 weeks, and 3 months post enrollment
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
A Jackson-Morris, P I Fujiwara, E Pevzner
https://pubmed.ncbi.nlm.nih.gov/26260816/Clemens Kruse, Jose Betancourt, Stephanie Ortiz...
https://pubmed.ncbi.nlm.nih.gov/31593543/John R Hughes, Josue P Keely, Ray S Niaura...
https://pubmed.ncbi.nlm.nih.gov/12745503/John D Murphy, Benmei Liu, Mark Parascandola
https://pubmed.ncbi.nlm.nih.gov/30165688/Alan R Lifson, Jacqueline Neuhaus, Jose Ramon Arribas...
https://pubmed.ncbi.nlm.nih.gov/20724677/Robert A Schnoll, Freda Patterson, E Paul Wileyto...
https://pubmed.ncbi.nlm.nih.gov/20124230/Kyra Guy, Jim Arinaitwe, Fastone Mathew Goma...
https://pubmed.ncbi.nlm.nih.gov/40074264/Heather Wipfli, Jim Arinaitwe, Fastone Goma...
https://pubmed.ncbi.nlm.nih.gov/40684230/Heather Wipfli, Jim Arinaitwe, Fastone Goma...
https://pubmed.ncbi.nlm.nih.gov/38243301/Julian A Mitton, Crystal M North, Daniel Muyanja...
https://pubmed.ncbi.nlm.nih.gov/29879856/University of Southern California
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor